HERDUO 250MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹3364.35

NATCO PHARMA LTD (ONCOLOGY DIV): Herduo 250MG Tablet, 30 tablets, salt lapatinib 250mg. NPPA has revised its MRP from Rs 6,000 to Rs 3,364.35 (44% lower) with effect from 09-11-2026; trade rate Rs 2,563.31. Group: HER2/EGFR tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Hetero, Neon, Novartis, Reliance Life Sciences and others. Handling/counselling: take on an empty stomach, at least one hour before or after food. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.